Coronary-heart-disease risk and impaired glucose tolerance. The Whitehall study
- PMID: 6104171
- DOI: 10.1016/s0140-6736(80)92651-3
Coronary-heart-disease risk and impaired glucose tolerance. The Whitehall study
Abstract
In the Whitehall Study of 18,403 male civil servants aged 40--64 years, 7 1/2 year coronary-heart-disease (CHD) mortality has been examined in relation to blood-sugar concentration 2 h after a 50 g oral glucose load. CHD mortality was approximately doubled for subjects with inpaired glucose tolerance (IGT), defined as a blood-sugar above the 95th centile (greater than or equal to 96 mg/dl). There was no trend of CHD mortality with blood-sugar below the 95th centile. Within the IGT group, age, systolic blood-pressure, and ECG abnormality (Whitehall criteria) were significantly predictive of subsequent CHD mortality. These findings are relevant to discussions on the criteria for diabetes which include the definition of an IGT category with increased risk of large-vessel disease, but without the high risk of small-vessel disease as occurs in diabetes mellitus.
Similar articles
-
Impaired glucose tolerance and its relationship to ECG-indicated coronary heart disease and risk factors among Chinese. Da Qing IGT and diabetes study.Diabetes Care. 1993 Jan;16(1):150-6. doi: 10.2337/diacare.16.1.150. Diabetes Care. 1993. PMID: 8422770
-
Mortality from coronary heart disease and stroke in relation to degree of glycaemia: the Whitehall study.Br Med J (Clin Res Ed). 1983 Sep 24;287(6396):867-70. doi: 10.1136/bmj.287.6396.867. Br Med J (Clin Res Ed). 1983. PMID: 6412862 Free PMC article.
-
Diabetes, hyperglycemia, and coronary heart disease.Prev Med. 1983 Jan;12(1):70-4. doi: 10.1016/0091-7435(83)90173-1. Prev Med. 1983. PMID: 6844320
-
Relation between blood glucose and coronary mortality over 33 years in the Whitehall Study.Diabetes Care. 2006 Jan;29(1):26-31. doi: 10.2337/diacare.29.01.06.dc05-1405. Diabetes Care. 2006. PMID: 16373891
-
Fasting, non-fasting glucose and HDL dysfunction in risk of pre-diabetes, diabetes, and coronary disease in non-diabetic adults.Acta Diabetol. 2013 Aug;50(4):519-28. doi: 10.1007/s00592-011-0313-x. Epub 2011 Jul 16. Acta Diabetol. 2013. PMID: 21769500
Cited by
-
Diuretics. Clinical pharmacology and therapeutic use (Part II).Drugs. 1985 Feb;29(2):162-88. doi: 10.2165/00003495-198529020-00003. Drugs. 1985. PMID: 3884320 Review.
-
Preferential elevation of protein kinase C isoform beta II and diacylglycerol levels in the aorta and heart of diabetic rats: differential reversibility to glycemic control by islet cell transplantation.Proc Natl Acad Sci U S A. 1992 Nov 15;89(22):11059-63. doi: 10.1073/pnas.89.22.11059. Proc Natl Acad Sci U S A. 1992. PMID: 1438315 Free PMC article.
-
Mortality and survival in type 2 (non-insulin-dependent) diabetes mellitus.Diabetologia. 1987 Mar;30(3):123-31. doi: 10.1007/BF00274216. Diabetologia. 1987. PMID: 3556287 Review. No abstract available.
-
Combined effects of maximal oxygen uptake and glucose status on mortality: The Prospective KIHD cohort study.Scand J Med Sci Sports. 2022 May;32(5):913-923. doi: 10.1111/sms.14135. Epub 2022 Feb 13. Scand J Med Sci Sports. 2022. PMID: 35103994 Free PMC article.
-
Ten-year atherosclerosis cardiovascular disease (ASCVD) risk score and its components among an Iranian population: a cohort-based cross-sectional study.BMC Cardiovasc Disord. 2022 Apr 9;22(1):162. doi: 10.1186/s12872-022-02601-0. BMC Cardiovasc Disord. 2022. PMID: 35397522 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Other Literature Sources
Medical